Not available
Quote | Paratek Pharmaceuticals Inc. (NASDAQ:PRTK)
Last: | $2.23 |
---|---|
Change Percent: | 1.79% |
Open: | $2.19 |
Close: | $2.23 |
High: | $2.24 |
Low: | $2.19 |
Volume: | 4,764,401 |
Last Trade Date Time: | 09/20/2023 03:00:00 am |
News | Paratek Pharmaceuticals Inc. (NASDAQ:PRTK)
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Paratek Pharmaceuticals Inc. (PRTK) is expected to report $-0.25 for Q3 2023
Message Board Posts | Paratek Pharmaceuticals Inc. (NASDAQ:PRTK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PRTK News Article - Paratek Pharmaceuticals to Report Financial Results for First Quar | whytestocks | investorshangout | 05/01/2023 6:00:50 PM |
znewcar1: $PRTK 35% f7,0M c1.86 f57,265M H1.920 RL=LL1.29 bO1.4 to push to hod a little choppy | znewcar1 | investorshangout | 03/21/2023 8:37:40 PM |
whytestocks: $PRTK News Article - Paratek Pharmaceuticals to Report Third-Quarter 2022 Financial Res | whytestocks | investorshangout | 10/25/2022 6:30:57 PM |
whytestocks: $PRTK News Article - Paratek Pharmaceuticals to Present at the H.C. Wainwright 24th Ann | whytestocks | investorshangout | 09/01/2022 5:20:52 PM |
whytestocks: $PRTK News Article - Paratek Appoints Minnie Baylor-Henry to Company's Board of Directo | whytestocks | investorshangout | 06/14/2021 12:25:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Paratek Pharmaceuticals Inc. Company Name:
PRTK Stock Symbol:
NASDAQ Market:
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Paratek Pharmaceuticals Inc. (PRTK) is expected to report $-0.25 for Q3 2023
BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military ...